Skip to main content

Table 2 Best overall response

From: A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Best Overall Response

n = 13 (%)

Partial Response (confirmed)

1 (7.7)

Partial Response (unconfirmed)

1 (7.7)

Stable Disease

5 (38.5)

Progressive Disease

6 (46.2)

Objective Response Rate

7.7%

Disease Control Rate

46.2%